Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

346 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-03-18

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Veterans can apply for compensation and pension (C \& P) benefits for a disability related to military service. The application exam for these benefits provides an opportunity for Veterans returning from service to access VA care. The investigators will recruit Veterans applying for C \& P to participate in this study. All enrolled participants will complete questionnaires around the time of their C \& P exam related to substance abuse, PTSD, service use, and attitudes. The investigators will monitor enrolled Veterans' attendance at treatment over time, and examine whether C \& P award, substance use, and beliefs about benefits are related to treatment attendance. Some enrolled participants will be assigned to one of two study groups: a treatment group and a no-additional-treatment group. People assigned to these groups will complete the same substance abuse, PTSD, service use, and attitudes questionnaires two additional times during the study. Participants assigned to the treatment group will receive information about the relationship between substance use and PTSD and will be referred to relevant treatment. The investigators will test whether Veterans who receive no-additional-treatment have different symptoms over time and attend less treatment sessions (mental health or substance abuse) than people assigned to treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intervening to Reduce Suicide Risk in Veterans With Substance Use Disorders

NCT02439762

Suicide Suicidal Ideation Substance-Related Disorders

COMPLETED NA

Impact of Work Activity on SUD Outcomes

NCT04969081

Substance-related Disorders

ACTIVE_NOT_RECRUITING NA

Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment

NCT01410110

Substance Abuse Substance Dependence Cognitive Impairment

COMPLETED PHASE2

Telephone Coaching of Family Members of Veterans With Substance Abuse Problems

NCT03246646

Substance Abuse

COMPLETED NA

Performance-based Reinforcement to Enhance Cognitive Remediation Therapy

NCT01633138

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Compensation examination that determines if a Veteran is entitled to any disability payments related to military service is a crucial gateway to accessing VA care for returning OEF/OIF Veterans. However, researchers and oversight agencies have noted that examiners typically do not have guidelines for evaluating comorbid conditions like substance abuse and for referring patients to treatment.

In the Evaluative Component of this study, OEF/OIF Veterans presenting for Compensation evaluations for PTSD will be approached to undergo a paid battery of confidential substance use, PTSD, service use and attitude assessments prior to their scheduled Compensation examinations. The batteries will be collected again twice, four and twelve weeks after the Compensation examinations. Long-term follow-up data will be extracted from VA databases including diagnoses, the results of the Veterans' Compensation evaluations, award determination, use of VA services and attendance at mental health and/or substance abuse treatment.

In the Clinical Trial Component of this study, one hundred sixty Veterans identified during the baseline evaluation as having a substance use disorder will be randomly assigned to a session of Screening, Brief Intervention and Referral to Treatment (SBIRT) or to No-Additional-Treatment. SBIRT is an approach to identifying and treating patients with substance abuse issues who are presenting for purposes other than substance abuse treatment. It involves Motivational Interviewing, which has been a consistently effective approach to facilitating engagement in substance abuse treatment in Veterans (Davis, Baer et al. 2003) and other populations. The study will examine factors associated with attendance at treatment including substance use, Veterans' beliefs about benefits, and compensation award. Group comparisons will be conducted on rates of treatment attendance, alcohol use, and PTSD symptoms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attendance at Treatment PTSD, Substance Use, and Attendance at Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SBIRT

The SBIRT-VA manual codifies basic substance abuse screening, treatment, Motivational Interviewing and referral procedures. It is designed for providers with minimal substance abuse expertise and is easy for experienced substance abuse providers to deliver.

Study sessions include identifying the Veterans' values through a card sort, the change ruler, on which the Veteran rates his/her willingness to change current behavior, listing the pros and cons of changing.

Group Type EXPERIMENTAL

SBIRT

Intervention Type BEHAVIORAL

SBIRT Therapy overview-

1. Therapist explains purpose of the therapy.
2. Inquiry about Compensation examination-ask if Veteran has questions about determination process and address concerns.
3. Discuss relationship between PTSD and substance use- long-term substance use is a form of avoidance and barrier to recovery.
4. Discuss treatment needs, administer screening, provide feedback.

No additional treatment

Veterans assigned to the control condition will not receive any study-related therapy. A Veteran who completes a Compensation examination ordinarily has no further treatment, referral, or debriefing as part of the Compensation examination.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SBIRT

SBIRT Therapy overview-

1. Therapist explains purpose of the therapy.
2. Inquiry about Compensation examination-ask if Veteran has questions about determination process and address concerns.
3. Discuss relationship between PTSD and substance use- long-term substance use is a form of avoidance and barrier to recovery.
4. Discuss treatment needs, administer screening, provide feedback.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Veteran of OEF or OIF,
* Not currently receiving VBA Compensation for PTSD,
* Able to participate psychologically and physically, able to give informed consent and complete, assessments, and participate in study procedures
* Between the ages of 18-65 years old.